cUTI Roundtable: Discussing and diagnosing these difficult infections

News
Video

This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.

We want to welcome you to the first episode from our complicated UTI roundtable series, which is a collaborative effort that includes Contemporary Pediatrics, Contagion, and Contemporary OB/GYN. This series looks to discuss several topics around these infections including diagnosis, treatment, challenges in managing UTIs in patients with dementia and neurogenic bladders, antibiotic resistance, and considerations for patients and caregiver engagement.

Our panel of clinicians includes:

  • Barbara Trautner, MD, PhD, professor, Infectious Diseases, Section of Health Services Research, Baylor College of Medicine
  • Kimberly Claeys, PharmD, associate professor of Practice, Sciences, and Health Outcomes Research, University of Maryland Baltimore
  • Laila Woc-Colburn, MD, associate professor, Division of Infectious Diseases, Emory University School of Medicine

This 3-part series that will be posted every Wednesday over the coming weeks. In today’s episode, the clinicians discuss what constitutes a complicated UTI and how does diagnosis and treatment differ between patient groups, such as men versus women, pregnant patients, or pediatric patients.

This roundtable is part of ongoing educational and informational multimedia series we are producing and for any feedback or suggestions, please feel free to email John Parkinson at jparkinson@mjhlifesciences.com.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Jillian Cotter, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.